Erin Fanning Madden, PhD, MPH

@efanningmadden.bsky.social

Substance use, stigma, & harm reduction researcher in Detroit. Also interested in qual methods, racism, immigration, & access to care. Sociologist working in a med school. Views are my own. She/her

Excellent succinct critique of the updated version of the Modernizing Opioid Treatment Access Act (MOTAA) introduced into the US senate. It still overregulates this lifesaving medication. We can do better.

Filter | harm reduction journalism@filtermag.bsky.social · yesterday

"Would MOTAA 2.0 unlock access for everyone who needs it?" asks @helenredmond.bsky.social. "The answer is no. Nothing in the updated bill addresses the fundamental problems in the 2023 version."

"Some states are represented by a single county; others by up to nine counties. There’s no standardization in how many sampling sites each county included, or whether multiple sites were spread out versus concentrated in one area."

White House Shares First Data From Wastewater Drug-Testing Project - Filter

The Office of National Drug Control Policy (ONDCP) has published its first report on wastewater-based drug testing, something that wasn’t ...

filtermag.org

Methadone is one of the most effective treatments for opioid addiction, yet federal law still limits access by making people to go through through specialty clinics. A new bipartisan bill would allow physicians to prescribe methadone directly through pharmacies, expanding access to life-saving care.

Bipartisan bill seeks to allow direct prescribing of methadone for opioid addiction

Methadone for opioid addiction has been available only at specialty clinics. A bipartisan bill would greatly expand access.

statnews.com

I got curious this year & asked my MPH students about their use of AI. A resounding "yuck" from all 20 students. One said she hates it but uses it because a prof said her writing was "too much like how she talks" and made her self conscious. Surely laziness drives use sometimes, but insecurity too!

Maia Szalavitz@maiasz.bsky.social · 2mo ago

excellent @alissaquart.bsky.social on AI and the banality of venal... www.motherjones.com/politics/202...

2 of many decisions that risk reversing our progress: "SAMHSA caution[ed] against the long-term use of methadone or buprenorphine... the Trump administration appointed Michael Stuart, a former WV state lawmaker best known for introducing legislation to ban methadone treatment, as the top HHS lawyer"

STAT@statnews.com · 2mo ago

Trump administration guidance reignites debate over methadone and buprenorphine www.statnews.com/2026/06/10/m...

The number of NIH competitive awards is down 50% from 2025, and down ~70% from prior years. Even if they catch up by the end of the year, only wealthy institutions can bridge these huge funding gaps.They're killing science-and violating the constitution-by weaponizing the bureaucracy

figure showing the trends I detail in the tweet text
The Washington Post@washingtonpost.com · 4mo ago

Through March 31, the number of grants awarded by the National Institutes of Health is down by more than half compared with the same period last year, a Post analysis found. There are also fewer grants focused on women’s health, cancer and mental health, the analysis found. https://wapo.st/48dWJWX

"Medetomidine can be thought of as the direct successor to xylazine. It's not associated with soft-tissue infections, but has distinct side effects of its own, including a withdrawal process that can require intensive hospital care."

CDC and ONDCP Issue Health Alert for Medetomidine, an Unusual Move

Medetomidine is the direct successor to xylazine. It's not associated with soft-tissue infections, but has distinct side effects of its own.

filtermag.org

Any SF harm reductionists want to weigh in on this *interesting* claim?: "Treatment and recovery became secondary goals, if they were goals at all... Harm reduction providers did not want to push users into treatment, worried [it] could [scare clients] away. The approach was all carrot, no stick."

New York Times Opinion@nytopinion.nytimes.com · 4mo ago

San Francisco was a model of Democratic governance gone wrong, but under a new mayor with a new approach to drug policy, it seems to have turned a corner, writes German Lopez. “The transformation is in its early stages, but what I saw in San Francisco was promising.”

Few of the things I work on at Science are purely fun, but the Dance your Ph.D contest is an exception. I'm always impressed by the creativity and enthusiasm of the entries. Graceful electrons and pole dancing analysis of pee? See this year's winners! www.science.org/content/arti...

And the winner of Science’s 2026 ‘Dance Your Ph.D.’ contest is …

A physicist and professional dancer takes home the grand prize, and Science awards its first trophy for an AI-assisted dance concept

science.org

Every time I have to go through the single IRB process as the relying (nonprimary) site it doesn’t really feel much shorter than having to go through a full IRB review. I thought the whole point of the single IRB model was to avoid multiple unnecessary IRB reviews?

I do want to shout-out my fellow sociologists, who have collectively created a discipline so woke that not a single one of our introductory textbooks can make it past Florida's censors. Great work everyone.

The Board of Governors decided, unilaterally, that no published textbook in the field of sociology could be used in compliance with the law for an Intro to Sociology class. None.
Victor: There's not a single existing textbook on the market that could be used that would qualify under state law?
Zachary: Correct.
Victor: I'm sorry, that's kind of funny. Like, the absurdity of not a single sociology textbook getting past the censors. I mean, it makes me kind of proud of our colleagues, but...